• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Addressing Vaccine Inequity - Covid-19 Vaccines as a Global Public Good.

作者信息

Hunter David J, Abdool Karim Salim S, Baden Lindsey R, Farrar Jeremy J, Hamel Mary Beth, Longo Dan L, Morrissey Stephen, Rubin Eric J

机构信息

From the Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom, and the Harvard T.H. Chan School of Public Health, Boston (D.J.H.); the Centre for the Aids Programme of Research in South Africa, Durban, and the Department of Epidemiology, Columbia Mailman School of Public Health, New York (S.A.K.); and the Wellcome Trust, London (J.J.F.).

出版信息

N Engl J Med. 2022 Mar 24;386(12):1176-1179. doi: 10.1056/NEJMe2202547. Epub 2022 Feb 23.

DOI:10.1056/NEJMe2202547
PMID:35196425
Abstract
摘要

相似文献

1
Addressing Vaccine Inequity - Covid-19 Vaccines as a Global Public Good.应对疫苗不平等——将新冠疫苗视为全球公共产品
N Engl J Med. 2022 Mar 24;386(12):1176-1179. doi: 10.1056/NEJMe2202547. Epub 2022 Feb 23.
2
Global Vaccine Inequity.全球疫苗不平等。
Am J Nurs. 2022 Apr 1;122(4):18-19. doi: 10.1097/01.NAJ.0000827304.78197.d3.
3
[Development and use of vaccines from the 18th century to the SARS-CoV 2 period].从18世纪到2019冠状病毒病时期疫苗的研发与应用
Ugeskr Laeger. 2021 Mar 15;183(11).
4
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
5
SARS-CoV-2 vaccine candidates in rapid development.正在快速开发的 SARS-CoV-2 疫苗候选物。
Hum Vaccin Immunother. 2021 Mar 4;17(3):644-653. doi: 10.1080/21645515.2020.1804777. Epub 2020 Oct 29.
6
Vaccine safety - is the SARS-CoV-2 vaccine any different?疫苗安全性 - SARS-CoV-2 疫苗有何不同？
Hum Vaccin Immunother. 2021 May 4;17(5):1322-1325. doi: 10.1080/21645515.2020.1829414. Epub 2020 Dec 3.
7
Coronavirus (SARS-CoV-2): a systematic review for potential vaccines.冠状病毒（SARS-CoV-2）：潜在疫苗的系统评价。
Hum Vaccin Immunother. 2022 Dec 31;18(1):1865774. doi: 10.1080/21645515.2020.1865774. Epub 2021 Feb 5.
8
Profiteering from vaccine inequity: a crime against humanity?从疫苗不公平中牟取暴利：反人类罪？
BMJ. 2021 Aug 16;374:n2027. doi: 10.1136/bmj.n2027.
9
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.辉瑞-生物科技和 Moderna 疫苗在 SARS-CoV-2 B.1.617.2（Delta）变异株广泛传播之前和期间预防养老院居民感染 SARS-CoV-2 的有效性 - 国家医疗保健安全网络，2021 年 3 月 1 日至 8 月 1 日。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3.
10
[SARS-CoV-2 vaccines].[严重急性呼吸综合征冠状病毒2型疫苗]
Ugeskr Laeger. 2021 Mar 8;183(10).

引用本文的文献

1
SARS-CoV-2 seroprevalence and COVID-19 vaccination coverage in two states of Nigeria from a population based household survey.基于人群的家庭调查得出的尼日利亚两个州的新冠病毒血清流行率和新冠疫苗接种覆盖率
Sci Rep. 2025 Aug 10;15(1):29272. doi: 10.1038/s41598-025-14253-z.
2
Embedding a commitment to equitable global access into basic and early-phase translational research.将对公平全球获取的承诺融入基础和早期转化研究中。
J Clin Transl Sci. 2025 Feb 25;9(1):e88. doi: 10.1017/cts.2024.691. eCollection 2025.
3
Effectiveness of vaccination (Sinopharm) among Covid-19 positive patients in a tertiary care hospital.
三级护理医院中新冠病毒检测呈阳性患者接种国药疫苗的有效性。
Arch Razi Inst. 2024 Oct 31;79(5):967-972. doi: 10.32592/ARI.2024.79.5.967. eCollection 2024 Oct.
4
Immunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, phase IV clinical trial in Brazil.新冠疫苗部分加强剂量与完整加强剂量的免疫原性和反应原性：巴西一项非劣效性、随机、双盲、IV期临床试验
Lancet Reg Health Am. 2025 Feb 22;44:101031. doi: 10.1016/j.lana.2025.101031. eCollection 2025 Apr.
5
Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study.东非和南部非洲艾滋病毒感染者中mRNA-1273的混合免疫与疫苗免疫：多中心CoVPN 3008（Ubuntu）研究的前瞻性队列分析
EClinicalMedicine. 2025 Jan 20;80:103054. doi: 10.1016/j.eclinm.2024.103054. eCollection 2025 Feb.
6
Psychological antecedents of vaccine inequity: keys to improve the rates of vaccination.疫苗不平等的心理成因：提高疫苗接种率的关键
J Egypt Public Health Assoc. 2024 Dec 4;99(1):31. doi: 10.1186/s42506-024-00175-7.
7
Biotechnological sovereignty is not a mere nationalist concept, it is a necessity for Colombia and Latin America.生物技术主权不仅仅是一个民族主义概念，它也是哥伦比亚和拉丁美洲的必要条件。
Cad Saude Publica. 2024 Sep 20;40(9):e00202323. doi: 10.1590/0102-311XEN202323. eCollection 2024.
8
High SARS-CoV-2 seroincidence but low excess COVID mortality in Sierra Leone in 2020-2022.2020年至2022年期间，塞拉利昂的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）血清阳性率高，但新冠超额死亡率低。
PLOS Glob Public Health. 2024 Sep 10;4(9):e0003411. doi: 10.1371/journal.pgph.0003411. eCollection 2024.
9
Treatments and the Perspectives of Developing a Vaccine for Chagas Disease.恰加斯病的治疗方法及开发疫苗的前景
Vaccines (Basel). 2024 Aug 1;12(8):870. doi: 10.3390/vaccines12080870.
10
Long COVID Syndrome: A Narrative Review on Burden of Age and Vaccination.长期新冠综合征：关于年龄负担和疫苗接种的叙述性综述
J Clin Med. 2024 Aug 13;13(16):4756. doi: 10.3390/jcm13164756.